Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ARIPIPRAZOLE
- Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis
- EFFECT OF RISPERIDONE vs ARIPIPRAZOLE ON OXIDATIVE STRESS IN PATIENTS WITH AUTISM SPECTRUM DISORDER: A RANDOMIZED CONTROLLED TRIAL
- A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Schizophrenia
- Sequenced Treatment in Adolescents With Major Depression (STAMD): a Multicenter Open-label Randomized Controlled Trial
- Bioequivalence Study of Aripiprazole From Apipe 10 mg Orally Disintegrating Tablets (Man. by: P&C Labs (Pellets & CR Products), Egypt) Versus Abilify 10 mg Orodispersible Tablets (Otsuka Pharmaceutical Netherlands B.V., Netherlands)
- Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT
- A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia
- VA Aripiprazole vs Esketamine for Treatment Resistant Depression
- Aripiprazole in Body Focused Repetitive Behaviors
- Bioequivalence Study of Aripiprazole in Healthy Adult Subjects Under Fasting Condition
- RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
- Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia
- The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia
- Impact of Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy
- Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder
- Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus Aripiprazole
- HALO Trial: Haloperidol vs Olanzapine in Hyperactive Delirium in Advanced Cancer Patients; A Multi-Centre, Randomised-Controlled Trial
- Brexpiprazole Treatment for Bipolar I Depression
- Pragmatic Trial of Obsessive-compulsive Disorder
- CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
- Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia
- Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building
- Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
- Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
- Brexpiprazole in Alcohol Use Disorder
- A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
- Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia
- A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
- Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
- Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder
- A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
- A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- Chinese First Episode Schizophrenia's Optimal Dynamic Antipsychotic Treatment Regime
- Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
- Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
- Substance Misuse To Psychosis for Stimulants
- A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
- CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)
- MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
- Aripiprazole Added on for DMDD in Youths With ADHD
- A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
- Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults
- Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
- Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
- Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study
- Aripiprazole IM Depot for Chinese Patients With Schizophrenia
- PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia
- Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
- Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia
- Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
- A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward Pathway
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up
- Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
- Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
- Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder
- Aripiprazole as an Adjunct to Atypical Antipsychotics for Weight Reduction and Improvement in Metabolic Profile
- The Optimal Treatment for Treatment-resistant Schizophrenia
- Enhancing Recovery in Early Schizophrenia
- Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
- Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
- Striatal Connectivity and Clinical Outcome in Psychosis
- Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance Spectroscopy
- Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators
- MEtformin and Lorcaserin for WeighT Loss in Schizophrenia
- Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
- Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
- A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder
- Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone
- A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia
- Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients
- A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia
- Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
- Antipsychotics and Risk of Hyperglycemic Emergencies
- Combination Treatment for Augmenting Language in Children With ASD
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-up
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-up
- Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs
- Comparative Bioavailability Study of Aripiprazole 10 mg Oral Soluble Film vs Abilify® 10 mg Tablet in Healthy Volunteers
- Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
- A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry
- Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin Extraction
- A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia
- A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform
- Pharmacovigilance in Gerontopsychiatric Patients
- Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics
- Fluoxetine vs Aripiprazole Comparative Trial (FACT)
- Pan European Collaboration on Antipsychotic Naïve Schizophrenia II
- Comparison of Aripiprazole Versus Risperidone on Brain Morphology Using MRI
- An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
- Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis
- Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
- Study of the Impact of Aripiprazole (Abilify®) Once Monthly Versus Standard of Care Oral Antipsychotic Medications on Changes in Brain Structure and Metabolism
- A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications
- A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia
- Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
- European Long-acting Antipsychotics in Schizophrenia Trial
- Antipsychotic to Treat Psychosis Syndrome
- A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects
- Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
- Study to Evaluate the Efficacy and Safety of Aripiprazole
- Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia
- Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
- Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia
- Adherence to Treatment, Safety and Tolerability Study of the Medical Information Device #1 (MIND1) in Subjects With Schizophrenia or Bipolar I Disorder
- Aripiprazole Once-monthly in Patients With Schizophrenia
- A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
- A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
- A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
- Antipsychotic Effects on Brain Function in Schizophrenia
- Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
- A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot
- 1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain
- An Study of Aripiprazole in the Treatment of Methamphetamine Dependence
- A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis
- Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
- Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
- A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
- Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
- Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- The Role of Antidepressants or Antipsychotics in Preventing Psychosis
- Pioglitazone for the Treatment of Bipolar Depression
- Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome
- Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
- Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients
- Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
- Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
- Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
- Canadian Biomarker Integration Network for Depression Study
- An Open Label Study of Aripiprazole Intramuscular Injection in Subjects With Schizophrenia
- A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
- A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five Antipsychotics
- Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
- Change in Brain Metabolism and Cognitive Function by Aripiprazole
- Safety and Tolerability Trial of Aripiprazole IM Depot Treatment in Adult Subjects With Schizophrenia Stabilized on Oral Antipsychotics Other Than Aripiprazole
- Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
- Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
- An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
- RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
- Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
- A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia
- Bergen Psychosis Project 2 - The Best Intro Study
- Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
- Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
- Aripiprazole for the Augmentation of Antidepressant Therapy
- A PET Study in Healthy Volunteers
- VA Augmentation and Switching Treatments for Improving Depression Outcomes
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)
- Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
- Aripiprazole and Resistant Postpartum Depression
- Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
- A Study of Safety and Tolerability in Subjects With Schizophrenia
- Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
- Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
- Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)
- A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients
- Aripiprazole Effects on Alcohol Drinking and Craving
- Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder
- Switching to Iloperidone From Other Antipsychotics in Schizophrenia
- Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
- Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects
- Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer
- Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone
- Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
- Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning
- 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
- Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)
- Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
- An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia
- A Long-Term, Open-Label, Study on Schizophrenia
- To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
- Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
- Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis
- Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
- Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
- Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
- Safety and Efficacy of Cariprazine in Patients With Schizophrenia
- Aripiprazole and Prolactin Study
- ARIpiprazole in Anorexia NErvosa
- Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
- Standard Comprehensive Intervention to Treat First-episode Schizophrenia
- Therapeutic Drug Monitoring in Child and Adolescent Psychiatry
- Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia
- Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and Quetiapine
- FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders
- Efficacy and Safety of Aripiprazole in First Episode Psychosis
- An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia
- Oral Aripiprazole Open-Label Rollover Study
- Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic Syndrome
- Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
- Trial of Aripiprazole in Trichotillomania
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
- Metabolic Effects of Antipsychotic Substitution in Children
- Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
- Examining the Effects of Antipsychotic Medications on Insulin Sensitivity
- Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)
- Aripiprazole and Topiramate on Free-Choice Alcohol Use
- Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
- Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
- Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression
- Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
- Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
- Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
- A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
- Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
- Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
- Comparison of Optimal Antipsychotic Treatments for Adults With Schizophrenia
- Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
- Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar Disorder
- A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial
- Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia
- Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
- Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
- Study to Demonstrate Cognitive Enhancing Effects of BF2.649
- Drug Interaction Study Between AZD3480 and Aripiprazole in Healthy Subjects
- Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
- A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
- An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence
- Study of Aripiprazole to Reduce Medical Risks in Bipolar Disorder
- Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
- A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
- Study of Aripiprazole to Treat Children and Adolescents With Autism
- Improving Metabolic Parameters of Antipsychotic Child Treatment With Ziprasidone, Aripiprazole, and Clozapine
- A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia.
- Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression
- A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
- A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
- A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
- A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
- Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
- Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia
- Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole
- The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
- Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents
- Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
- Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia
- Health Evaluation of Abilify Long-term Therapy
- Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia
- A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome
- Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
- Aripiprazole Augmentation of Antidepressants in PTSD
- The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia
- ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
- Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
- The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial
- Efficacy of Aripiprazole Versus Placebo in the Reduction of Aggressive and Aberrant Behavior in Autistic Children
- Metabolic Signatures and Biomarkers in Schizophrenia
- Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms
- Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia
- Aripiprazole for the Treatment of Refractory Anxiety
- Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder
- A Prospective Open-label Study of Aripiprazole in Fragile X Syndrome
- Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia
- Study of Aripiprazole in Patients With Schizophrenia- Effects on Glucose Metabolism-
- Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)
- Effects of Aripiprazole on Cocaine Craving and Self-Administration
- Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
- A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression
- Aripiprazole and Effexor XR Drug Interaction Study
- Aripiprazole and Lexapro Drug Interaction Study
- The New Strategy for Pharmacological Treatment in People With Schizophrenia
- A Placebo-Controlled, Cross-Over Trial of Aripiprazole
- Switch Study of Existing Atypical Antipsychotics to Bifeprunox
- Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
- Xyrem for Treatment Refractory Insomnia Due to PTSD
- Effect on Cognitive Function of a Treatment With Aripiprazole
- Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.
- Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I Disorder
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode Psychosis
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
- An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders
- Aripiprazole Associated With Methylphenidate in Children and Adolescents With Bipolar Disorder and ADHD
- Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)
- SWitching to Abilify Trial (SWAT)
- A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
- Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
- A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
- Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
- Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
- Aripiprazole in the Treatment of Tourette's Syndrome
- Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
- A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
- Aripiprazole Augmentation Therapy in Treatment-resistant Depression
- Aripiprazole to Reduce Cocaine Relapse
- A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
- Study of Aripiprazole in Patients With Bipolar I Disorder
- A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication
- Trial of Aripiprazole in the Treatment of CD in Adolescents
- Side Effects of Newer Antipsychotics in Older Adults
- Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder
- Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials
- A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
- Schizophrenia Trial of Aripiprazole
- Aripiprazole Treatment of Prodromal Patients
- A Switch Study of BMS-337039 in Schizophrenic Out-patients
- Aripiprazole in the Treatment of Bipolar Depression
- The Effects of Aripiprazole on Patients With Metabolic Syndrome
- 12- Week Open Label Treatment of Refractory Bipolar Depression
- Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
- The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
- Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)
- An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder
- Abilify as an Adjunctive Treatment for Refractory Depression
- Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder
- A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)
- Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)
- The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia
- Aripiprazole in Children With Autism: A Pilot Study
- Abilify Therapy for Reducing Comorbid Substance Abuse
- Metabolic Effects of Antipsychotics in Children
- Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
- Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
- Aripiprazole Treatment of Bipolar Depression
- Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
- A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
- Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
- Aripiprazole in Late Life Bipolar Disorder
- Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder
- Aripiprazole Effects on Alcohol Reactivity and Consumption
- Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder
- Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
- Aripiprazole as Augmentation for TRD
- Aripiprazole Treatment of the Prodrome
- Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study
- Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia
- Aripiprazole in Children and Adolescents With Bipolar Disorder and Attention Deficit Hyperactivity Disorder (ADHD)
- Aripiprazole in Children and Adolescents With Bipolar I Disorder
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
- A Study of Aripiprazole in Patients With Major Depressive Disorder
- Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia
- Aripiprazole Open-Label, Safety and Tolerability Study
- Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and Adolescents
- Aripiprazole in Adolescents With Schizophrenia
- Aripiprazole Oral Acceptability Trial
- Study of Aripiprazole in Patients With Acute Bipolar Mania
- A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
- Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
- A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
- A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
- Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
- Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
- Aripiprazole in Patients With Acute Mania
- A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
- Assessment of Interactions Between Methamphetamine and Aripiprazole - 1
- Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia
- Study of Aripiprazole in Subjects With Alcoholism
- Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
- Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode
- RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders
- Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder
- Switching Medication to Treat Schizophrenia
- Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
- Broad Effectiveness: Study With Aripiprazole
- Study of Aripiprazole in Patients With a History of Bipolar Disorder
- Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
- Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
- Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
- CATIE- Schizophrenia Trial
Clinical trials list
click for details